CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Parallax Health Sciences Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Parallax Health Sciences Inc
3415 s. sepulveda blvd suite 1100-6592
Phone: (424) 239-9979p:424 239-9979 Los Angeles, CA  90034  United States

This company is no longer actively traded on any major stock exchange.

Business Summary
Parallax Health Sciences, Inc. is a healthcare company that is focused on developing products and services and provides remote communication, diagnosis, treatment, and monitoring of patients on a proprietary platform. The Company’s business segments include Remote Patient Monitoring (RPM), Behavioral Health Services (BHS) and Diagnostics/Corporate. The Remote Patient Monitoring segment has developed a distinctive technology platform Fotodigm platform and Fotodigm. Behavioral Health Services segment offers REBOOT and Intrinsic Code technologies. The Diagnostics/Corporate Segment provides management and administrative services to support the Company and consists of certain aspects of the Company’s executive management, corporate relations, legal, compliance, human resources, and corporate information technology and finance departments.
(Source: 10-K)

Scores and Ratings
FRISK®
Score
Z''
Score
PAYCE®
Score
DBT
Index
Moody's
Rating
Fitch
Rating
DBRS
Rating
-Yes-----

Financials, News and Filings
Latest
Statement
Last
Audit

News
SEC
Filings
Bankruptcy
Filings
Suit &
Judgment
Filings
Tax
Lien
Filings
12/31/201912/31/2019YesYes-Yes-

Officers and Directors

Title

Name

Age
Title
Date
Start
Date
Chairman of the Board, President David L.Stark 62 3/25/2022 3/1/2020
Chief Financial Officer, Treasurer, Secretary, Director Calli R.Bucci 56 3/28/2022 11/1/2012
Director John L.Ogden 1/1/2017 1/1/2017

Subsidiaries
Business Name Address City State/Province Country
RoxSan Pharmacy, Inc. 465 North Roxbury Drive Beverly Hills CA United States

Business Names
Business Name
Endeavor Holdings, Inc.
Endeavor Power Corp
Endeavor Uranium Inc.
7 additional Business Names available in full report.

General Information
Number of Employees: 9 (As of 12/31/2019)
Outstanding Shares: 270,723,289 (As of 5/15/2020)
Shareholders: 9
Stock Exchange: OTC
Federal Tax Id: 721619357
Email Address: info@endeavoruranium.com


Copyright © 2023 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Saturday, July 22, 2023